FDA Rejects Vanda Pharma's Application for Gastroparesis Drug Tradipitant
The Food and Drug Administration has turned away a proposed drug from Vanda Pharmaceuticals to treat the stomach disorder gastroparesis. Vanda on Thursday said the FDA has issued a so-called complete response letter for the drug,
The FDA is citing the presence of a government-regulated ingredient due to its possible hazards for children and adults. The ...
2d
The Food and Drug Administration (FDA) is looking to propose the inclusion of front-of-package warning labels that detail the ...
FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of important documents from a facility ...
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement ...
Tremfya is now approved for the treatment of plaque psoriasis, active psoriatic arthritis and ulcerative colitis.
2h
Elanco Animal Health Inc. (ELAN) announced the U.S. Food and Drug Administration has approved Zenrelia, a convenient once-daily oral ...
Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?
On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and children 12 ...
Women with early-stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the ...
On August 6, 2024, the Food and Drug Administration (FDA) partnered with the Clinical Trials Transformation Initiative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback